Australian Researchers Test Reprogramming Adult Stem Cells
This article was originally published in PharmAsia News
Australian researchers say they have succeeded in testing human stem cells without an egg, a technique designed to avoid the controversy of using human embryos for research. The work is the first successful test of the technique outside Japan or the United States. Monash University's Australian Stem Cell Centre obtained U.S. adult cells to reprogram to make them behave more like embryonic stem cells as a new way of obtaining induced pluripotent stem cells. (Click here for more
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.